Ibrahim Abouleish | |
|---|---|
إبراهيم أبو العيش | |
Abouleish in 2007 | |
| Born | (1937-03-23)23 March 1937 Mashtul, Egypt |
| Died | 15 June 2017(2017-06-15) (aged 80) Egypt |
| Occupation | Pharmaceutical |
| Known for | SEKEM |
| Awards | Right Livelihood Award |
Ibrahim Abouleish (Arabic:إبراهيم أبو العيش; 23 March 1937 – 15 June 2017)[1] was an Egyptian philanthropist, drug designer and chemist. He began his chemistry and medicine studies at the age of 19 in Austria. He did his doctorate in 1969 in the field of pharmacology and then worked in leading positions within pharmaceutical research. During this time he was granted patents for a number of new medicines,[2] especially forosteoporosis andarteriosclerosis.
In 1977 he returned to Egypt and founded the comprehensive development initiativeSEKEM. The organisation began usingbiodynamic farming methods in Egypt, successfully demonstrating a model forsustainable agriculture on arid desert lands without requiring irrigation. Abouleish later expanded SEKEM to include aWaldorf school, a medical center, various businesses, and adult education initiatives ranging fromvocational training to the establishment ofHeliopolis University.
He was selected as an "OutstandingSocial Entrepreneur" by theSchwab Foundation in 2004.[3] In 2006 he was appointed as a councillor at theWorld Future Council.[4] In 2012, Dr. Ibrahim Abouleish was appointed an Oslo Business for Peace Honouree, receiving his award at Oslo City Hall, fromThe Business for Peace Foundation.In 2013 he received the[5] Global Thinkers Forum 2013 Award for Excellence in Positive Change. In 2003, he was awarded theRight Livelihood Award for "a 21st century business model which combines commercial success with social and cultural development."